nootropic

1. Min 98% 2. Bulk in stock 3. Analysis report offer

1. Direct manufacture 2. Min 99%, Analysis report attached 3. Cheap price

1. Min 98%, analysis report offer 2. Large in stock 3. Good price

Wuhan HHD High Quality Nootropics Product

1. Wuhan hengheda pharm offer wholesale Sulbutiamine 2. high quality with analysis report 3. in stock and fast delivery

1. Wuhan hengheda Pharm factory supply Idebenone 2. cheap price Idebenone with high quality 3. In stock and fast delivery

N-phenethyl Dimethylamie(Eria Jarensis Extract) was claimed to be a assy extracted from a plant called Eria Jarensis. It is a new PEA-like molecule that has very nice euphoric effect. However the effect are quite mild which is not as strong as DMAA. N-Phenethyl Dimethylamine(Eria Jarensis Extract) has similar effects and functions as a neuromodulartor in the central nervous system. Although naturally-occurring,it is frequently supplemented as for its therapeutic mood-boosting benefits,so it actually boost our dopamine levels which may make our brain feel better.

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1). As a dimer of twomodified thiamine molecules, it is a lipophilic compound that crosses the blood-brain barrier more readily than thiamine and increases the levels of thiamine and thiamine phosphate esters in the brain. Sulbutiamine was discovered in Japan in an effort to develop more useful thiamine derivatives since it was hoped that increasing the lipophilicity of thiamine would result in better pharmacokinetic properties. Sulbutiamine’s nootropic properties boost both physical and mental levels in the body leaving you with a feeling of high energy. It is used primarily to treat a condition called asthenia and fatigue. Sulbutiamine is another great nootropic to help with mood. Some people have compared Sulbutiamine to ’s anxiolytic and antidepressant qualities without the stimulation. Also from wikipeidia reference citation, Several studies have shown that sulbutiamine improves memory through the potentiation of cholinergic, dopaminergic, and glutamatergic transmission. When sulbutiamine is administered to mice, they perform better on operant conditioning tests and object recognition tests. Sulbutiamine also reduces the amnesiac effects of dizocilpine and improves memory in schizophrenics.

Being one of the newer entrants to the Racetam family of drugs, Coluracetam (buy from hhdpharm) was first registered with PubChem in 2005 by the Mitsubishi Tanabe Pharma Corporation and later handed off to BrainCells Inc, who has done a majority of the testing on it, including the Phase 2A trials which were completed in 2010 . Upon completion of the Phase 2A trials, BrainCells announced that Coluracetam showed promise as a treatment for Major Depressive Disorder co-morbid with Generalized Anxiety Disorder, but did not show significant results treating participants who only had one of those disorders. Coluracetam (buy from hhdpharm) appears to have two well-defined mechanisms of action; the first being high-affinity choline uptake, and the other being AMPA potentiation . As is the case with a few of the Racetams, Coluracetam has been show to facilitate AMPA potentiation which is known to increase alertness, memory, and learning capabilities. What is more intriguing about Coluracetam are its high-affinity choline uptake properties; choline uptake plays a crucial role in the Acetylcholine synthesis process in the brain by acting as a rate-limiter. This rate-limiting step allows the brain to convert choline into Acetylcholine in the neuron, and by increasing the high-affinity choline uptake the brain is more readily able to convert choline to Acetylcholine; by increasing the ability to convert choline to Acetylcholine, should in theory improve attention, memory, and wakefulness in humans.